Mindpeak, a leader in AI software for pathology, has announced a groundbreaking collaboration with Roche to revolutionize cancer diagnostics through the integration of Mindpeak's innovative AI algorithm with Roche's Digital Pathology Open Environment. This partnership is set to play a pivotal role in helping clinicians enhance patient care and expand personalized medicine.
Game-Changing Integration for Improved Healthcare
In a healthcare landscape where laboratories are at the forefront of diagnostic tests, the integration of cutting-edge technologies is essential. To address the challenges posed by rising data volume and the need for efficient, cost-effective testing, Roche's navify® Digital Pathology enterprise software now seamlessly incorporates Mindpeak's AI algorithms. This integration offers a solution to reduce errors, enhance workflow efficiency, and provide real-time tracking of key laboratory KPIs.
Elevating Diagnostic Precision with AI
Mindpeak's integration into the navify® Digital Pathology platform is designed to elevate diagnostic precision and facilitate precision medicine, ultimately leading to superior patient care. This comprehensive digital pathology solution enables seamless interdepartmental collaboration and structured access to therapy-relevant patient data.
Pioneering AI Solutions for Pathology
Mindpeak stands as a pioneer in AI solutions for clinical laboratories and biopharma companies, with over 30,000 patients diagnosed using Mindpeak's AI and more than 20 publications in prestigious journals and conferences. Their AI algorithms were the first to be employed in digital pathology for routine clinical diagnostics in both the USA and the EU.
For more information on Mindpeak and their innovative AI solutions, visit their website at www.mindpeak.ai
CONTACT: Mindpeak GmbH
Katja Eisele
Email: katja.eisele@mindpeak.ai
GERMANY EUROPE
TECHNOLOGY MEDICAL DEVICES HEALTH SOFTWARE BIOTECHNOLOGY ARTIFICIAL INTELLIGENCE ONCOLOGY
SOURCE: Mindpeak
Copyright Business Wire 2024.